Operating Margin of Stoke Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Stoke Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Stoke Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was 13%.
  • Stoke Therapeutics, Inc. annual Operating Margin for 2024 was -277%, a 79% increase from 2023.
  • Stoke Therapeutics, Inc. annual Operating Margin for 2023 was -1307%, a 55% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Stoke Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 13% +714% 01 Jul 2025 30 Sep 2025
Q2 2025 20% +776% 01 Apr 2025 30 Jun 2025
Q1 2025 20% +1530% 01 Jan 2025 31 Mar 2025
Q4 2024 -277% +1030% +79% 01 Oct 2024 31 Dec 2024
Q3 2024 -701% +514% +42% 01 Jul 2024 30 Sep 2024
Q2 2024 -756% +514% +40% 01 Apr 2024 30 Jun 2024
Q1 2024 -1510% -794% -111% 01 Jan 2024 31 Mar 2024
Q4 2023 -1307% -466% -55% 01 Oct 2023 31 Dec 2023
Q3 2023 -1215% 01 Jul 2023 30 Sep 2023
Q2 2023 -1269% 01 Apr 2023 30 Jun 2023
Q1 2023 -716% 01 Jan 2023 31 Mar 2023
Q4 2022 -841% 01 Oct 2022 31 Dec 2022

Stoke Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -277% +1030% +79% 01 Jan 2024 31 Dec 2024
2023 -1307% -466% -55% 01 Jan 2023 31 Dec 2023
2022 -841% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.